Development of a monoclonal antibody to reverse overdose from fentanyl and its analogs: from manufacturing to clinical trials

Project: Research project

Project Details

Description

Development of a monoclonal antibody to reverse overdose from fentanyl and its analogs: from manufacturing to clinical trials
StatusFinished
Effective start/end date9/30/229/29/23

Funding

  • UNIVERSITY OF WASHINGTON
  • NATIONAL INSTITUTES OF HEALTH (NIH)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.